Decisions of Annual General Meeting of AS Harju Elekter Group The Annual General Meeting of Shareholders of AS Harju Elekter Group was held on 26 April 2024 starting at 14 p.m., at the Swissotel Tallinn, Tornimäe 3. The AGM was attended by 60 shareholders and their authorised representatives who represented a total of 11,324,722 votes accounting for 61.22% of the total votes. The decisions of the General Meeting were as follows:1. Approval to AS Harju Elekter Group annual report of 2023 Approve the 2023 Annual Report prepared by the Management Board and approved by the Sup...
AS-i Harju Elekter Group aktsionäride üldkoosoleku otsused 26. aprillil 2024 kell 14 toimus Swissotel Tallinn AS-i Harju Elekter Group (registrikood 10029524, aadress Paldiski mnt 31/2, Keila) aktsionäride korraline üldkoosolek. Üldkoosolekust võttis osa 60 aktsionäri ja nende volitatud esindajat, kes olid esindatud kokku 11 324 722 häälega, mis moodustab häälte üldarvust 61,22%. AS-i Harju Elekter Group aktsionäride üldkoosolek otsustas:1. AS-i Harju Elekter Group 2023. a majandusaasta aruande kinnitamine Kinnitada AS-i Harju Elekter Group juhatuse poolt koostatud ja nõukogu pool...
A director at Meitu Inc sold 66,050,180 shares at 2.915HKD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
A director at Kesko Oyj bought 10,000 shares at 15.756EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Savencia : Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023 Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023 La société annonce avoir mis à disposition du public et déposé auprès de l’Autorité des Marchés Financiers son rapport financier annuel au 31 décembre 2023. Le rapport financier annuel peut être consulté sur le site internet de la société à l’adresse -fromagedairy.com, dans la rubrique « information réglementée ». Viroflay, le 26 avril 2024 Pièce jointe
Two Directors at SSAB AB bought 15,813 shares at between 60.100SEK and 61.060SEK. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Two Directors at WiseTech Global Limited sold 226,758 shares at 89.790AUD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
A director at THG bought 30,000 shares at 63p and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close ...
Weekly Comment Summary After two weeks of seasonal-related buying at the start of April, foreign investors turned net sellers in the third week. Has foreign investor enthusiasm for Japanese shares come to an end? And is the yen to blame? Pelham Smithers investigates. PSA Company Visits, Tours and Interviews • Visited: CUC (9158 JT) • Conference Call with: Insource (6200 JT) • Presentations at: CUC (9158 JT), Shin-Etsu Chemical (4063 JT), TDK (6762 JT), Asahi Kasei (3407 JT), Nitto Denko (6988...
Crédit Agricole Normandie Seine : communiqué financier trimestriel au 31 mars 2024 RESULTATS AU 31 MARS 2024 Bois-Guillaume, le 26 avril 2024 Un premier trimestre de l’année 2024 impacté par un contexte économique en berne Impactée par le contexte économique européen de faible croissance, l’activité du 1er trimestre 2024 a été marquée par une faible dynamique d’investissement des entreprises et des ménages du territoire. Ce trimestre a été pour la Caisse Régionale Normandie-Seine un temps fort de rencontre de nos clients, illustrant l’intensité relationnelle que nous souhaito...
Correction Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement MUNICH, Germany, April 26, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”) (OTC: SEVCF), a solar technology company, today announced a correction to its press release issued on April 25, 2024, which provided an update on the trading symbol for the Company's ordinary shares and introduced the new leadership team. The original press release incorrectly stated that the Company's ordinary shares would be quoted on the over-the-counter market under the U.S. ticker ...
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma $15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)ALLO-316 Illustrates Proof-of-Concept in RCC and the Potential of Dagger® Technology to Optimize CAR T Cell Expansion and Persistence SOUTH SAN FRANCISCO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology comp...
Mount Logan Capital Inc. Schedules Release of First Quarter 2024 Results TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan” or the “Company”) will release its financial results for the first quarter ended March 31, 2024 after market close on Thursday, May 9, 2024. The Company will host a conference call on Friday, May 10, 2024, at 11:00 a.m. Eastern Time to discuss these results. Shareholders, prospective shareholders, and analysts are welcome to listen to the conference call. To join the call, please use the dial-in information below. A recordi...
Rigetti Computing Launches the Novera™ QPU Partner Program The Novera QPU Partner Program aims to enable high-performing, on-premises quantum computing by creating an ecosystem of quantum computing hardware, software, and service providers who build and offer integral components of a functional quantum computing system. Novera QPU customers can work with Novera QPU partners to build a quantum computer powered by the Novera QPU that satisfies their system requirements and quantum computing research objectives. BERKELEY, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. ...
CEMATRIX Announces $7.6 Million in New Contracts and a Reduction in Scope of a Previously Awarded Tunnel Project CALGARY, Alberta, April 26, 2024 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company") a North American leading manufacturer and supplier of technologically advanced cellular concrete products today announced that it has executed $7.6 million in new contracts. A portion of the $7.6 million in new contracts is derived from two projects, with price tags greater than $1 million Canadian, and were previously included in Contracts in Proc...
Exagen Inc. Announces Changes to the Board of Directors CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn, Ph.D. is joining the Board as a Class I Director. Dr. Kahn has a distinguished career in life sciences spending over 30 years in global leadership positions. Prior to starting his career in the life science industry, he was an assistant professor of organic chemistry at the University of Illinois. He spent ove...
Bannix Acquisition Corp. Receives Nasdaq Notification of Non-Compliance With Listing Rules WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on April 25, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company did not...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.